Argen X SE Ret. on equity

What is the Ret. on equity of Argen X SE?

The Ret. on equity of Argen X SE is -33.02%

What is the definition of Ret. on equity?



Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.

ttm (trailing twelve months)

The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.

Ret. on equity of companies in the Health Care sector on NASDAQ compared to Argen X SE

What does Argen X SE do?

Argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.

Companies with ret. on equity similar to Argen X SE